New England Securities’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q4
$27K Buy
1,200
+200
+20% +$4.5K 0.01% 775
2014
Q3
$16K Buy
+1,000
New +$16K 0.01% 992